Wednesday, February 22, 2012
   |  Careers  |  News Letter  |  Digital Edition
 
Showcase
1/23/2012
Sandoz launches Galantamine oral solution
Sandoz is pleased to announce the launch of Sandoz Galantamine 4mg/ml oral solution - the
generic version of Reminyl oral solution by Shire.
Galantamine is a drug used to treat the symptoms of mild to moderately severe dementia of the Alzheimer type, a disease that alters brain function.
Sandoz Galantamine 4mg/ml oral solution became available from 17th January 2012 through AAH
& Unichem. For more information email mailbox.sandoz-gb@sandoz.com or call 01276 698020
Bookmark and Share
 
More News
•  Incredisocks keeps diabetes firmly on the ground
•  Cura-Heat – the UK’s number one selling heat pack brand
•  Imigran Recovery - tackling the root cause of migraines
•  Teva launches Latanoprost Eye Drops
•  Say goodbye to dry eye with Systane
•  EyevitPlus - vital nutrients for good vision
•  Sycrest - new and effective treatment for bipolar disorder
•  Vicks VapoRub – unblocking noses for 100 years
•  LanesHealth launches Kalms Day Pocket Pack
•  Forest Laboratories introduces AriPro - hydrating barrier mousse
 
 
 
Winner's Profile
Remote pharmacy
 
The 2011 Numark Conference
 
 
Read Online
 
 
Copyright © 2012. Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc